These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16454681)

  • 1. Development of a novel high-throughput assay for the investigation of GlyT-1b neurotransmitter transporter function.
    Allan L; Leith JL; Papakosta M; Morrow JA; Irving NG; McFerran BW; Clark AG
    Comb Chem High Throughput Screen; 2006 Jan; 9(1):9-14. PubMed ID: 16454681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a fluorescent imaging plate reader membrane potential assay for high-throughput screening of glycine transporter modulators.
    Benjamin ER; Skelton J; Hanway D; Olanrewaju S; Pruthi F; Ilyin VI; Lavery D; Victory SF; Valenzano KJ
    J Biomol Screen; 2005 Jun; 10(4):365-73. PubMed ID: 15964938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms.
    Harsing LG; Timar J; Szabo G; Udvari S; Nagy KM; Marko B; Zsilla G; Czompa A; Tapolcsanyi P; Kocsis A; Matyus P
    Curr Pharm Des; 2015; 21(17):2291-303. PubMed ID: 25578890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes.
    Herdon HJ; Godfrey FM; Brown AM; Coulton S; Evans JR; Cairns WJ
    Neuropharmacology; 2001 Jul; 41(1):88-96. PubMed ID: 11445189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycine transporter-1: a new potential therapeutic target for schizophrenia.
    Hashimoto K
    Curr Pharm Des; 2011; 17(2):112-20. PubMed ID: 21355838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes.
    Kim KM; Kingsmore SF; Han H; Yang-Feng TL; Godinot N; Seldin MF; Caron MG; Giros B
    Mol Pharmacol; 1994 Apr; 45(4):608-17. PubMed ID: 8183239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4'-fluorophenyl)-3-(4'phenylphenoxy)propyl])sarcosine.
    Mallorga PJ; Williams JB; Jacobson M; Marques R; Chaudhary A; Conn PJ; Pettibone DJ; Sur C
    Neuropharmacology; 2003 Oct; 45(5):585-93. PubMed ID: 12941372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between glycine transporter type 1 (GlyT-1) and some inhibitor molecules - glycine transporter type 1 and its inhibitors (review).
    Harsing LG; Zsilla G; Matyus P; Nagy KM; Marko B; Gyarmati Z; Timar J
    Acta Physiol Hung; 2012 Mar; 99(1):1-17. PubMed ID: 22425803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model.
    Mohammadzadeh A; Lakatos PP; Balogh M; Zádor F; Karádi DÁ; Zádori ZS; Király K; Galambos AR; Barsi S; Riba P; Benyhe S; Köles L; Tábi T; Szökő É; Harsing LG; Al-Khrasani M
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a scintillation proximity assay for analysis of Na+/Cl- -dependent neurotransmitter transporter activity.
    Williams JB; Mallorga PJ; Lemaire W; Williams DL; Na S; Patel S; Conn PJ; Pettibone DJ; Austin C; Sur C
    Anal Biochem; 2003 Oct; 321(1):31-7. PubMed ID: 12963052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acylglycinamides as inhibitors of glycine transporter type 1.
    Blunt R; Porter R; Johns A; Nash D; Puckey G; Wyman P; Herdon H; Teague S; Hadden V; Fontana S; Gordon L
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6176-9. PubMed ID: 21889344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane domains 1 and 3 of the glycine transporter GLYT1 contain structural determinants of N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)-propyl]sarcosine specificity.
    Núñez E; Martínez-Maza R; Geerlings A; Aragón C; López-Corcuera B
    Neuropharmacology; 2005 Nov; 49(6):922-34. PubMed ID: 16143353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice.
    Kopec K; Flood DG; Gasior M; McKenna BA; Zuvich E; Schreiber J; Salvino JM; Durkin JT; Ator MA; Marino MJ
    Biochem Pharmacol; 2010 Nov; 80(9):1407-17. PubMed ID: 20637735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive N-methyl-D-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo.
    Whitehead KJ; Pearce SM; Walker G; Sundaram H; Hill D; Bowery NG
    Neuroscience; 2004; 126(2):381-90. PubMed ID: 15207356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hypoxia-induced [(3)H]glycine release from chicken retina by the glycine transporter type-1 (GlyT-1) inhibitors NFPS and Org-24461.
    Harsing LG; Albert M; Matyus P; Szenasi G
    Exp Eye Res; 2012 Jan; 94(1):6-12. PubMed ID: 22079563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter.
    Atkinson BN; Bell SC; De Vivo M; Kowalski LR; Lechner SM; Ognyanov VI; Tham CS; Tsai C; Jia J; Ashton D; Klitenick MA
    Mol Pharmacol; 2001 Dec; 60(6):1414-20. PubMed ID: 11723250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of [³H]CHIBA-3007 binding to glycine transporter 1 in the rat brain.
    Zhang J; Wu J; Toyohara J; Fujita Y; Chen H; Hashimoto K
    PLoS One; 2011; 6(6):e21322. PubMed ID: 21731704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a gene encoding two glycine transporter variants reveals alternative promoter usage and a novel gene structure.
    Borowsky B; Hoffman BJ
    J Biol Chem; 1998 Oct; 273(44):29077-85. PubMed ID: 9786914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of glycine transport in the frog retina.
    Pérez-León JA; López-Vera E; Salceda R
    Neurochem Res; 2004 Jan; 29(1):313-8. PubMed ID: 14992291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.